Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Cancer × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 25 Breast Neoplasms 16 Neoplasms 9 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Sarcoma 5 Pancreatic Neoplasms 5 Fanconi Anemia, Complementation Group D1 5 Endometrial Neoplasms 5 Small Cell Lung Carcinoma 4 Recurrence 4 Colorectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Metastatic Castration-resistant Prostate Cancer 2 Glioma 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Solid Tumor 1

Interventions

Nivolumab 10 Surveys and Questionnaires 6 Bevacizumab 5 linrodostat 4 Standard of Care 4 Ipilimumab 4 Interviews as Topic 4 Docetaxel 4 temsirolimus 3 Sirolimus 3 Pemetrexed 3 Paclitaxel 3 Gemcitabine 3 Erlotinib Hydrochloride 3 Cetuximab 3 ARRY-334543 3 relatlimab 2 regorafenib 2 abemaciclib 2 Vorinostat 2 Trastuzumab 2 Sorafenib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Carboplatin 2 vorolanib 1 vistusertib 1 trametinib 1 tislelizumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02338622 2024-09-26

ComPAKT

Royal Marsden NHS Foundation Trust

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡